List of works by Paul Kirschmeier

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

scientific article published on 14 March 2019

Unraveling the clinicopathological features driving the emergence of mutations in metastatic breast cancer

Paulina is supported by:

About Paulina

Help